Growth drug shows promise for kids with dwarfism
NCT ID NCT03424018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called BMN 111 in children with achondroplasia, the most common form of dwarfism. The goal is to see if it safely helps them grow taller over several years. About 119 children who completed an earlier study will take the drug and be monitored for growth, daily activities, and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acibadem University School of Medicine
Istanbul, 34752, Turkey (Türkiye)
-
Alfred I. duPont Hospital for Children
Wilmington, Delaware, 19803, United States
-
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Children's Hospital & Research Center Oakland
Oakland, California, 94609, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital
London, SE1 9RT, United Kingdom
-
Harbor - UCLA Medical Center
Torrance, California, 90509, United States
-
Hospital Sant Joan de Deu
Barcelona, 08950, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
Institut Catala de Traumatologica I Medicina de l'Esport
Barcelona, 08028, Spain
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Medical College of Wisconsin, Children's Hospital
Milwaukee, Wisconsin, 53226, United States
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
Osaka University Hospital
Osaka, Japan
-
Otto-von-Gericke Universitaet, Universitaetskinderklinik
Magdeburg, 39120, Germany
-
Saitama Children's Medical Center
Saitama, Japan
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
Sheffield Children's NHS Foundation Trust
Sheffield, S10 2TH, United Kingdom
-
The Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
-
Tokushima University Hospital
Tokushima, Japan
-
University of Missouri
Columbia, Missouri, 65201, United States
-
Universitätsklinikum Münster
Münster, 48149, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly shot help children with achondroplasia grow taller?
- Can growth hormone boost height in children with dwarfism?
- Weekly shot may boost growth in kids with dwarfism
- Experimental achondroplasia drug trial halted early
- No treatment, just tracking: PROPEL study watches how kids with achondroplasia grow
- New drug aims to boost height in kids with dwarfism